ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Advanced/Metastatic NSCLC With PD-L1 ≥ 50% and Without Actionable Genomic Alterations
By
ASCO 2022 Conference Coverage
FEATURING
Benjamin Levy
By
ASCO 2022 Conference Coverage
FEATURING
Benjamin Levy
121 views
June 10, 2022
Login to view comments.
Click here to Login
Lung